Clinical Trials
2 trialsNCT02739360 2020-03-04
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
Gilead Sciences
Phase 4 Terminated
NCT01013818 2013-08-02
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Human Genome Sciences Inc.
Phase 1 Terminated